ImmuCell
ICCC
24 hedge funds and large institutions have $3.17M invested in ImmuCell in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
14% more funds holding
Funds holding: 21 → 24 (+3)
4.75% less ownership
Funds ownership: 14.06% → 9.31% (-4.8%)
18% less capital invested
Capital invested by funds: $3.84M → $3.17M (-$676K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Overbrook Management Corp
New York
|
+$384K |
| 2 |
Renaissance Technologies
New York
|
+$86.3K |
| 3 |
RC
RBF Capital
San Francisco,
California
|
+$57K |
| 4 |
FHA
Flagship Harbor Advisors
Boston,
Massachusetts
|
+$54K |
| 5 |
BlackRock
New York
|
+$24.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.46M |
| 2 |
ISL
Ingalls & Snyder LLC
New York
|
-$384K |
| 3 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$43.6K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| – | +$17 | +4 | New |
|
ICCC Hedge Fund Activity: Q2 2020 in Review
24 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2020, worth a combined $3.17M — down 18% from $3.84M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ICCC positions and 3 closed out — a net gain of 3 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Overbrook Management Corp, opening a new position worth an estimated $384K. The largest seller was Wellington Management Group, exiting entirely with an estimated $1.46M sold.
- 24 institutional investors held ImmuCell (ICCC) as of Q2 2020, up from 21 in Q1 2020.
- Funds reported $3.17M of ImmuCell stock for Q2 2020, down 18% quarter-over-quarter.
- 6 funds opened new ImmuCell positions in Q2 2020 and 3 closed out, a net change of +3 holders.
- The largest ImmuCell buyer in Q2 2020 was Overbrook Management Corp, an estimated $384K added.
- The largest ImmuCell seller in Q2 2020 was Wellington Management Group, an estimated $1.46M sold.
Based on aggregated 13F filings for Q2 2020.